Medicare Enrolled
Dr. Chippy Ajithan, MD
Cardiovascular Disease · Sarasota, FL
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Ajithan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Ajithan?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Ajithan
Dr. Chippy Ajithan is a cardiovascular disease specialist in Sarasota, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Ajithan performed 6,153 Medicare services across 4,403 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ajithan received a total of $4,264 from 29 pharmaceutical and/or device companies across 270 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ajithan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 16% volume in FL
$4,264 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 84450 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary
Medicare Utilization ↗6,153
Medicare services
Top 16% in FL for cardiovascular disease
4,403
Unique beneficiaries
$118
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~308 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,419 | $92 | $197 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
859 | $11 | $40 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
672 | $42 | $103 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
372 | $145 | $465 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
308 | $95 | $200 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
278 | $64 | $139 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 248 | $318 | $798 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
244 | $52 | $182 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
194 | $90 | $236 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
158 | $38 | $102 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
151 | $31 | $84 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
149 | $38 | $120 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
130 | $140 | $389 |
| New patient office visit, complex (60-74 min) | 123 | $161 | $387 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
111 | $141 | $698 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
98 | $335 | $861 |
| 2-day continuous ECG with review and report A two-day continuous electrocardiogram recording that includes a professional review and written report of the results. |
90 | $51 | $226 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
82 | $123 | $266 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle while at rest and during stress. |
72 | $1,176 | $2,359 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
64 | $62 | $129 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
52 | $2,140 | $4,315 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
38 | $21 | $54 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
38 | $627 | $929 |
| Heart muscle strain imaging | 26 | $9 | $79 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
25 | $70 | $202 |
| Aminophylline injection, up to 250 mg Administration of aminophylline medication via injection for a dose of up to 250 mg. |
24 | $7 | $25 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
23 | $13 | $38 |
| Blood glucose level test A test that measures the amount of sugar in your blood. |
23 | $4 | $11 |
| Liver enzyme (SGOT) level test A blood test that measures the level of the liver enzyme SGOT to help assess liver health. |
23 | $5 | $15 |
| Liver enzyme (SGPT) level test A blood test that measures the level of the liver enzyme SGPT to assess liver function. |
23 | $5 | $15 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
12 | $85 | $227 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
12 | $14 | $41 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
12 | $2 | $22 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
6.2% high complexity
23.3% medium
70.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,264
Total received (2018-2024)
Avg $609/year across 7 years
Top 43% in FL for cardiovascular disease
29
Companies
270
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,165 (97.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$99 (2.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$566
2023
$462
2022
$585
2021
$583
2020
$251
2019
$862
2018
$954
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$904
Amgen Inc.
$480
PFIZER INC.
$431
Janssen Pharmaceuticals, Inc
$390
SANOFI-AVENTIS U.S. LLC
$365
Merck Sharp & Dohme LLC
$344
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$237
Lexicon Pharmaceuticals, Inc.
$122
Astellas Pharma US Inc
$122
Boehringer Ingelheim Pharmaceuticals, Inc.
$109
E.R. Squibb & Sons, L.L.C.
$97
Kestra Medical Technology Services, Inc.
$88
Merck Sharp & Dohme Corporation
$85
AstraZeneca Pharmaceuticals LP
$64
Boston Scientific Corporation
$62
Regeneron Healthcare Solutions, Inc.
$46
Acutus Medical, Inc.
$40
Novo Nordisk Inc
$39
Allergan Inc.
$34
Kiniksa Pharmaceuticals, Ltd.
$29
Medtronic, Inc.
$25
CVRx, Inc.
$25
Abbott Laboratories
$22
BOSTON SCIENTIFIC CORPORATION
$19
Esperion Therapeutics, Inc.
$19
Kiniksa Pharmaceuticals International, plc
$19
Alnylam Pharmaceuticals Inc.
$18
Sobi, Inc
$14
Relypsa, Inc.
$13
Top 3 companies account for 42.6% of total payments
Associated products mentioned in payments ›
Arcalyst · Assure WCD · BRILINTA · BYSTOLIC · Barostim Neo System · CAMZYOS · Corlanor · ELIQUIS · ENTRESTO · FARXIGA · Inpefa · JARDIANCE · LEQVIO · LINQ II · LifeVest · MULTAQ · Mitra Clip system · NEXLETOL · ONPATTRO · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · RESONATE · Repatha · Rybelsus · TEGSEDI · VERQUVO · VYNDAQEL · Veltassa · Veozah · WATCHMAN · WATCHMAN Access System · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $69 per 100 Medicare services performed
Geographic Context
Cardiologists within 10 mi
79
Per 100K population
17.6
County median income
$80,633
Nearest hospital
SARASOTA MEMORIAL HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ajithan is a clinical cardiology specialist, with above-average Medicare volume (top 16% in FL), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ajithan experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Ajithan performed 1,419 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Ajithan receive payments from pharmaceutical companies?
Yes. Dr. Ajithan received a total of $4,264 from 29 companies across 270 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Ajithan's costs compare to other cardiologists in Sarasota?
Dr. Ajithan's average Medicare payment per service is $118. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Ajithan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Sarasota
Browse cardiologists in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in FL
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in FL
Which FL cardiologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology